OCT — Clinical Trials in Russia, Central and Eastern Europe
OCT Clinical Trials
OCT is a local CRO providing high-quality services in clinical trials conduct in the CEE region.
We are 65 people now and our clinical team includes only medical doctors in Russia, Ukraine, Bulgaria, Belarus, Baltic States and Czech Republic.
OCT expertise covers a broad range of therapeutic areas due to the accumulated experience of our staff.
We are dedicated to speedy recruitment, timely project implementation and individual approach.
News
- Phase III trial in breast cancer started
- Enrolment of 1223 patients completed
- A Phase II trial in endometrial cancer started
- A device trial in surgery started
- A Phase III trial in mastocytosis started
- OCT started collaboration with RUSNANO
- A Phase IV pediatric trial in acute bronchitis started
- An exclusive collaboration agreement signed
- Completion of enrolment in Crohn’s disease
- Completion of enrolment in 18 sites in cardiology study
- Prolongation of enrolment for breast cancer study
- 3 post-marketing studies launched in 120 sites in Russia
- OCT QA department starts investigator GCP training for Novartis
- OCT is starting a new diabetes trial in 10 sites in Russia
- OCT is initiating breast cancer trial in Russia
- OCT successfully finished the study in breast cancer
- OCT signed the contract to increase the number of countries from 5 to 7 in erectile dysfunction study
- Professional team
- Joint experience
- High-quality services
- Local expertise
- Customer oriented approach
- Competitive pricing
- Quick response
Events
OCT Vision
“OCT vision is to be recognized by pharmaceutical and biotech companies as one of the leaders in providing clinical trial services in Eastern Europe and Russia, a reliable partner, a solidary team of professionals, and CRO they want to collaborate with once again. Our core values are satisfied sponsors and investigators, international strategic long term CRO partnership, high quality data/services, flexible and customized approach, experienced and trained company staff”, — Dmitry Sharov, General Manager of OCT.